A specialty pharmaceutical company commercializing ZECUITY® sumatriptan iontophoretic transdermal system (patch) for the acute treatment of migraine. In February 2014, NuPathe was acquired by Teva Pharmaceutical Industries.
NuPathe Pharma
![NuPathe Pharma](http://baycitycapital.com/wp-content/uploads/2014/04/portfolio-nupathe.jpg)
A specialty pharmaceutical company commercializing ZECUITY® sumatriptan iontophoretic transdermal system (patch) for the acute treatment of migraine. In February 2014, NuPathe was acquired by Teva Pharmaceutical Industries.